Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Daniela Caldirola, Alessandra Alciati, Alice Riva & Giampaolo Perna. (2018) Are there advances in pharmacotherapy for panic disorder? A systematic review of the past five years. Expert Opinion on Pharmacotherapy 19:12, pages 1357-1368.
Read now
Read now
Giampaolo Perna, Koen Schruers, Alessandra Alciati & Daniela Caldirola. (2015) Novel investigational therapeutics for panic disorder. Expert Opinion on Investigational Drugs 24:4, pages 491-505.
Read now
Read now
Articles from other publishers (18)
Yiding Han, Haohao Yan, Xiaoxiao Shan, Huabing Li, Feng Liu, Guojun Xie, Ping Li & Wenbin Guo. (2023) Enhanced interhemispheric resting-state functional connectivity of the visual network is an early treatment response of paroxetine in patients with panic disorder. European Archives of Psychiatry and Clinical Neuroscience.
Crossref
Crossref
Asmatullah Khan, Muhammad Akram, Muthu Thiruvengadam, Muhammad Daniyal, Shahbaz Ahmad Zakki, Naveed Munir, Rida Zainab, Mojtaba Heydari, Seyed Hamdollah Mosavat, Maksim Rebezov & Mohammad Ali Shariati. (2022) Anti-anxiety Properties of Selected Medicinal Plants. Current Pharmaceutical Biotechnology 23:8, pages 1041-1060.
Crossref
Crossref
Tália Cássia Boff, Silvio José Batista Soares, Millena Daher Medeiros Lima & Zuleide Maria Ignácio. 2022. Glutamate and Neuropsychiatric Disorders. Glutamate and Neuropsychiatric Disorders
539
570
.
Guizhen Chen, Xue Wang, Shuo Zhang, Xiaokang Xu, Junquan Liang & Yunxiang Xu. (2020) In vivo investigation on bio-markers of perimenopausal panic disorder and catgut embedding acupoints mechanism. Medicine 99:19, pages e19909.
Crossref
Crossref
Mohamed S. Zulfarina, Syed-Badrul Syarifah-Noratiqah, Shuid A. Nazrun, Razinah Sharif & Isa Naina-Mohamed. (2019) Pharmacological Therapy in Panic Disorder: Current Guidelines and Novel Drugs Discovery for Treatment-resistant Patient. Clinical Psychopharmacology and Neuroscience 17:2, pages 145-154.
Crossref
Crossref
Morena M. Zugliani, Mariana C. Cabo, Antonio E. Nardi, Giampaolo Perna & Rafael C. Freire. (2019) Pharmacological and Neuromodulatory Treatments for Panic Disorder: Clinical Trials from 2010 to 2018. Psychiatry Investigation 16:1, pages 50-58.
Crossref
Crossref
Mu-Hong Chen & Shih-Jen Tsai. 2019. Treatment Resistance in Psychiatry. Treatment Resistance in Psychiatry
189
206
.
Giampaolo Perna & Daniela Caldirola. (2017) Management of Treatment-Resistant Panic Disorder. Current Treatment Options in Psychiatry 4:4, pages 371-386.
Crossref
Crossref
Daniela Caldirola, Massimiliano Grassi, Alessandra Alciati, Alice Riva, Erika Sangiorgio, Silvia Daccò & Giampaolo Perna. (2017) Personalized medicine in panic disorder: where are we now? A meta-regression analysis. Personalized Medicine in Psychiatry 1-2, pages 26-38.
Crossref
Crossref
Mu-Hong Chen & Shih-Jen Tsai. (2016) Treatment-resistant panic disorder: clinical significance, concept and management. Progress in Neuro-Psychopharmacology and Biological Psychiatry 70, pages 219-226.
Crossref
Crossref
Giampaolo Perna, Alciati Alessandra, Balletta Raffaele, Mingotto Elisa, Diaferia Giuseppina, Cavedini Paolo, Nobile Maria & Caldirola Daniela. (2016) Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines. International Journal of Molecular Sciences 17:4, pages 551.
Crossref
Crossref
Ariadna Amador, Yongjun Wang, Subhashis Banerjee, Theodore M. Kameneka, Laura A. Solt & Thomas P. Burris. (2016) Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression. PLOS ONE 11:3, pages e0151014.
Crossref
Crossref
Giampaolo Perna, Alessandra Alciati, Alice Riva, Wilma Micieli & Daniela Caldirola. (2016) Long-Term Pharmacological Treatments of Anxiety Disorders: An Updated Systematic Review. Current Psychiatry Reports 18:3.
Crossref
Crossref
Emin Mehmet Ceylan, Bariş Önen Ünsalver & Alper Evrensel. (2016) Medial Cranial Fossa Meningioma Diagnosed as Mixed Anxiety Disorder with Dissociative Symptoms and Vertigo. Case Reports in Psychiatry 2016, pages 1-3.
Crossref
Crossref
Philip L. Johnson, Lauren M. Federici & Anantha Shekhar. (2014) Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks. Neuroscience & Biobehavioral Reviews 46, pages 429-454.
Crossref
Crossref
Heidi Combs & Jesse Markman. (2014) Anxiety Disorders in Primary Care. Medical Clinics of North America 98:5, pages 1007-1023.
Crossref
Crossref
Miles D. Thompson, Henri Xhaard, Takeshi Sakurai, Innocenzo Rainero & Jyrki P. Kukkonen. (2014) OX1 and OX2 orexin/hypocretin receptor pharmacogenetics. Frontiers in Neuroscience 8.
Crossref
Crossref
Elizabeth A. Lungwitz, Andrei Molosh, Philip L. Johnson, Brian P. Harvey, Rachel C. Dirks, Amy Dietrich, Pamela Minick, Anantha Shekhar & William A. Truitt. (2012) Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats. Physiology & Behavior 107:5, pages 726-732.
Crossref
Crossref